Ads
related to: who should not take linzess
Search results
Results From The WOW.Com Content Network
Linaclotide, (sold under the brand name Linzess in the US and Mexico, and as Constella elsewhere) [6] is a drug used to treat irritable bowel syndrome with constipation and chronic constipation with no known cause.
In college, I did not feel good at all in my body. I knew something was wrong, and I wanted to get to the bottom of it. ... (IBS) and decided to put me on a medication called Linzess, a daily pill ...
Plecanatide has not been shown to be safe or effective in persons 6 years to 18 years of age. [12] Use of plecanatide by persons under the age of 6 poses a serious dehydration risk and studies have demonstrated plecanatide can cause death in juvenile mice due to this dehydrating effect.
Ironwood Pharmaceuticals (NAS: IRWD) Linzess got the early FDA approvals flowing this week. Yesterday, the biotech announced that the FDA had approved Linzess, its treatment for irritable bowel ...
The effectiveness of lubiprostone has not been established in patients who are taking a diphenylheptane opioid (e.g., methadone). [3] [12] Irritable bowel syndrome with constipation (IBS-C; a condition that causes stomach pain or cramps, bloating, and infrequent or difficult passage of stools) in women who are at least 18 years of age.
Ironwood Pharmaceuticals Provides Third Quarter 2012 Investor Update - Received FDA Approval of LINZESS™ (linaclotide) for Treatment of Adult Patients with IBS-C or CIC; Prepared for Commercial ...
Ad
related to: who should not take linzess